Oncology & Cancer

New drug combination passes safety test in pancreatic cancer

A new study has shown a novel peptide antagonist, given in combination with a PD-1 inhibitor, to be safe and well-tolerated in patients with advanced, refractory pancreatic and rectal cancer. The highest dose tested had a ...

Medications

Three-drug combination reduces COPD patient mortality

Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according ...

Medications

New drug combination may improve cold sore treatment

Research from Kent's School of Biosciences and the Goethe-University Frankfurt am Main, has found a drug combination that may improve treatment for diseases caused by herpes simplex viruses such as cold sore, genital herpes, ...

page 1 from 48